Abstract
Macrophages play a pivotal role at all stages of progression of atherosclerosis. However, the macrophage-targeted treatment of atherosclerosis remains elusive. Recently, macrophage-targeted gene therapy via lipid polymer nanoparticles (NPs) to improve the atherosclerotic plaque stability in mice was reported.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have